De Mangia A et al. Global real world evidence of sofosbuvir/verplatasvir as a simple effective regimen for the treatment of chronic hepatitis C patients: Integrated analysis of 12 clinical practice cohorts. (Abstract GS-03)
Europese goedkeuring voor bezlotoxumab ter preventie van terugkerende infectie met CDI
apr 2017 | Antibioticaresistentie